|Articles|October 7, 2015

Nobel Prize for Parasitic Disease Research

October 07, 2015.

The 2015 Nobel Prize in Physiology or Medicine has been awarded to researchers in the US, Japan, and China for developing therapies to combat river blindness, lymphatic filariasis, and malaria which "have revolutionized the treatment of some of the most devastating parasitic diseases". For more, visit the Pharmaceutical Technology story here.

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Trending on PharmExec

Nobel Prize for Parasitic Disease Research

Related Content

Utilizing 100-Percent Domestic Additive Manufacturing: Q&A with Kyle Smith

Insilico Announces Collaboration with SK Biopharmaceutical for AI-Powered CNS Treatment

Additive Manufacturing's Application in Pharma and Biotech

Expanding the Vaccine Landscape with New Technologies: Q&A with Silvia Taylor

The ROI of Smarter Trials: Q&A with Raj Indupuri

Trending on PharmExec

EMA’s CHMP Recommends Eli Lilly’s Jaypirca for Approval

Reading Between the Lines: Closing the T1D Misdiagnosis Gap

Pharmaceutical Executive Daily: FDA Clears Trodelvy for First-Line Metastatic Triple-Negative Breast Cancer

Novartis Announces $105 Million Collaborative Agreement with Antares Therapeutics

The Rise of Direct-to-Patient Models in Pharma: Opportunities and Risks in Bypassing Traditional Distribution Channels